You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis

Article info

Article menu

Download PDFPDF

Case Report
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
Free

Authors

  • A Doran Bostwick Departments of Internal Medicine and PediatricsDuke University Medical Center 27710 Durham NC USA PubMed articlesGoogle scholar articles
  • April K Salama Melanoma Program, Division of Medical Oncology, Department of Internal MedicineDuke University Medical Center Box 2639 203 Research Drive, MSRB1, Room 397 27710 Durham NC USA PubMed articlesGoogle scholar articles
  • Brent A Hanks Melanoma Program, Division of Medical Oncology, Department of Internal MedicineDuke University Medical Center Box 2639 203 Research Drive, MSRB1, Room 397 27710 Durham NC USA PubMed articlesGoogle scholar articles
  1. ↵a anne.bostwick{at}dm.duke.edu
  2. ↵b april.salama{at}dm.duke.edu
  3. ↵c hanks004{at}mc.duke.edu
View Full Text

Citation

Bostwick AD, Salama AK, Hanks BA
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
Journal for ImmunoTherapy of Cancer 2015;3:19. doi: 10.1186/s40425-015-0064-2

Publication history

  • Received December 15, 2014
  • Accepted April 24, 2015
  • First published May 19, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2015